Pharmacokinetics of Diclofenac and Hydroxypropyl‐β‐Cyclodextrin (HPβCD) Following Administration of Injectable HPβCD‐Diclofenac in Subjects With Mild to Moderate Renal Insufficiency or Mild Hepatic Impairment

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|7|2|110-122

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.7, Iss.2, 2018-02, pp. : 110-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PLGA Microparticles Encapsulating Prostaglandin E1-Hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH)

By Gupta Vivek   Davis Marauo   Hope-Weeks Louisa   Ahsan Fakhrul  

Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. : 1733-1749

Springer Publishing Company

Access to resources Recommend Favorite

Pulmonary Delivery of Deslorelin: Large-Porous PLGA Particles and HPβCD Complexes

By Koushik Kavitha   Dhanda Devender S.   Cheruvu Narayan P. S.   Kompella Uday B.  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1119-1126

Springer Publishing Company

Access to resources Recommend Favorite

Preparation of Tiagabine HCl/2-HP&bgr;CD Complex Pellets by Extrusion-Spheronization Using Glycerol Monostearate as Pellet-Aid

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 1, 2010-01 ,pp. : 63-69

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Multiple-Dose Darunavir in Combination with Low-Dose Ritonavir in Individuals with Mild-to-Moderate Hepatic Impairment

By Sekar Vanitha  

Clinical Pharmacokinetics, Vol. 49, Iss. 5, 2010-05 ,pp. : 343-350

Adis International

Access to resources Recommend Favorite

No Influence of Mild-To-Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

By Wåhlander K.   Eriksson-Lepkowska M.   Frison L.   Fager G.   Eriksson U.G.  

Clinical Pharmacokinetics, Vol. 42, Iss. 8, 2003-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite